Sarepta Therapeutics (SRPT) PT Lowered to $105 at BofA Securities
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Price: $18.10 --0%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 10
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 10
Join SI Premium – FREE
BofA Securities analyst Tazeen Ahmad lowered the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $105.00 (from $122.00) while maintaining a Buy rating.
You May Also Be Interested In
- Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
- Allianz SE (ALV:GR) (AZSEY) PT Raised to EUR460 at JPMorgan
- NKT A/S (NKT:DC) PT Lowered to DKK916 at Barclays
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
